As a dedicated supporter of the small cell lung cancer (SCLC) community, Jazz is focused on driving awareness of the fact that there is nothing small or unimportant about SCLC. To support this goal, Jazz and collaborators from the broader healthcare community launched Nothing Small About It (NSAI), a campaign providing solutions to reduce SCLC-related disparities.
Today is an exciting and transformative day for Jazz Pharmaceuticals as we complete the acquisition of @GW Pharmaceuticals and its U.S. subsidiary, @Greenwich Biosciences, a world leader in the science, development and commercialization of regulatory approved cannabinoid medicines.
August 1 marks World Lung Cancer Day. Under normal circumstances, this would be an opportunity to raise awareness of a disease that accounts for nearly one in five cancer deaths globally while sharing information about risk factors and highlighting the importance of early detection.
When Cammy was seven weeks old, Meghan, Cammy’s mother, recognized that something wasn’t right when Cammy’s arm would shake involuntarily. After a number of tests and a visit to the hospital, Cammy was diagnosed with tuberous sclerosis complex, a rare form of epilepsy. It was in this moment that both Meghan and Cammy’s lives would change forever.
During National Family Caregivers Month, we recognize and honor family caregivers who dedicate time and resources to caring for their loved ones. Jazz is committed to raising awareness of the essential role that caregivers play and the challenges they face, and to educating communities on ways to increase support for them.
Living an adventurous life at the age of 22, Caroline thought she was pursuing her dream. At the time, she was living in Korea, where she was teaching elementary school and applying for her Ph.D. after completing a bachelor’s degree in Immunology from the University of Edinburgh. She never would have suspected that what she thought was just a regular cold, maybe caught from her young students, would ultimately lead to a life-changing and potentially life-threatening diagnosis.
Epilepsy is a neurological disorder characterized by the occurrence of at least two unprovoked seizures occurring more than 24 hours apart or by one unprovoked seizure with a high probability of further seizures.
Idiopathic hypersomnia (IH) is a debilitating neurologic sleep disorder characterized by chronic excessive daytime sleepiness. Despite the physical and mental impact of the condition, the road to diagnosis and appropriate treatment can be long and filled with challenges.
Those who have recently heard the words ’you have cancer’ or ’we need to start you on a treatment regimen right away’ may have experienced overwhelming feelings around the extensive list of possible side effects from treatment.
At Jazz Pharmaceuticals, we’re committed to developing life-changing medicines for people affected by serious diseases for which current therapies are lacking. This begins with talking to those living with disease and reflecting their needs in our R&D priorities and throughout all stages of our drug development process as we pursue novel, meaningful medicines that advance patient care.
Bruce Cozadd, our Chief Executive Officer, looks back on Jazz’s major achievements of 2021 amid ongoing challenges of the pandemic, reflecting on the significant strides made for patient populations, and reinstating Jazz’s continued commitment to developing breakthrough therapeutics as we kick off 2022.
In November, our Jazz Association of Women Supporters employee-led Affinity Forum hosted an exciting virtual event for our members to discuss allyship for women, and the various actions we can all take to be an ally to advocate for women and their career development.
